A Study of the C3 Complement Inhibitor AMY-101 in Adults With Gingivitis
Clinical trial NCT03694444 · COMPLETED
Trial details
- NCT number
- NCT03694444
- Sponsor
- Amyndas Pharmaceuticals S.A.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-22
- Primary completion
- 2020-08-30
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.